首页> 外国专利> Antigen sequences for use in preventive treatment of HCV and/or HBV infection, compositions of HCV antigen sequences for use in preventive treatment of HCV and/or HBV infections, chimeric virus-like particles displaying HCV antigen sequences, a HCV and/or HBV vaccine

Antigen sequences for use in preventive treatment of HCV and/or HBV infection, compositions of HCV antigen sequences for use in preventive treatment of HCV and/or HBV infections, chimeric virus-like particles displaying HCV antigen sequences, a HCV and/or HBV vaccine

机译：用于预防性治疗HCV和/或HBV感染的抗原序列，用于预防性治疗HCV和/或HBV感染的HCV抗原序列的组成，展示HCV抗原序列的嵌合病毒样颗粒，HCV和/或HBV疫苗

页面导航

摘要
著录项
相似文献

摘要

The report refers to the sequence of selected epitopes constituting antigenic sequences from the glycoprotein E2 range for HCV and/or HBV preventive treatment and more specifically for use as a recombinant vaccine based on these epitopes in the form of chemeric virus-like molecules based on sHBsAg protein. The notification also covers HCV-like chemical particles based on the protein sHBsAg of the HBV virus that exhibit selected HCV antigen sequences in selected systems. The notification shall also cover an immunogenic vaccine for use in the prevention of HCV and/or HBV infections,which are based on these selected sequences according to the solution and composition of hepatitis C HCV antigens, as well as a chemical protein containing a small surface protein of hepatitis B virus.

机译：该报告涉及从糖蛋白E2范围构成抗原序列的选定抗原决定簇的序列，用于HCV和/或HBV预防治疗，更具体地讲，是基于这些抗原决定簇的重组疫苗，以基于sHBsAg的嵌合病毒样分子的形式使用蛋白。该通知还涵盖了基于HBV病毒sHBsAg蛋白的HCV样化学颗粒，这些颗粒在选定的系统中表现出选定的HCV抗原序列。通知还应包括用于预防HCV和/或HBV感染的免疫原性疫苗，该疫苗基于丙型肝炎HCV抗原的溶液和组成以及包含小的表面的化学蛋白质，基于这些选定的序列乙型肝炎病毒的蛋白质。

著录项

公开/公告号PL427320A1

专利类型
公开/公告日2020-04-06

原文格式PDF
申请/专利权人 UNIWERSYTET GDAŃSKI;
展开▼

申请/专利号PL20180427320
发明设计人 KATARZYNA GRZYB;ANNA CZARNOTA;KRYSTYNA BIEŃKOWSKA-SZEWCZYK;
展开▼

申请日2018-10-01
分类号A61K39/29;A61K39/295;C07K14/02;
国家 PL
入库时间 2022-08-21 11:16:28

相似文献

专利
外文文献
中文文献